StonvexLoading…
StonvexStonvexStonvexCore line items from CBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $29.46M | $121.60M | $91.65M | $30.77M |
Operating Income | $11.86M | $47.42M | $35.05M | $11.20M |
Net Income | $9.53M | $37.20M | $27.06M | $8.69M |
EPS (Diluted) | $0.70 | $2.95 | $2.22 | $0.72 |
Total Assets | $2.33B | $2.29B | $2.21B | Not available |
Total Liabilities | $2.04B | $2.01B | $1.97B | Not available |
Cash & Equivalents | $168.39M | $144.32M | $154.79M | $150.49M |
Free Cash Flow OCF − CapEx | $13.11M | $35.23M | $26.46M | $11.73M |
Shares Outstanding | 13.70M | 13.70M | 12.24M | 12.14M |